Case Challenge

Management of Dyslipidemia in an HIV-Infected Man With Grave Cardiac Risk

Source: Managing Cardiovascular Risk in HIV-Infected Patients: The Role of Antiretroviral Selection

Management of Dyslipidemia in an HIV-Infected Man With Grave Cardiac Risk

Faculty:

Jens D. Lundgren, MD, DMSc
Signe Westring Worm, MD

CME CREDIT INFORMATION

Release Date: 11/20/07

Expiration Date: 11/19/08

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Name the factors that are included in the assessment of 10-year cardiovascular risk by the Framingham calculation
Discuss guideline recommendations for treatment of dyslipidemia in HIV-infected patients
Describe the role of statins in the treatment of dyslipidemia in HIV-infected patients
Explain how modification of antiretroviral therapy contributes to the management of dyslipidemia in HIV-infected patients

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.